Related Experiment Video

Updated: Jun 2, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K

Defining a lineage-specific chimerism threshold for the use of donor lymphocyte infusions in treating myeloid

Christian J Puzo1, Stuart Seropian2, Henry Rinder3

  • 1Yale School of Medicine, New Haven, CT, USA.

Bone Marrow Transplantation
|January 13, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.2K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.2K

Related Experiment Videos

Last Updated: Jun 2, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.2K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.2K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277

Articles linked to this work by shared authors, journal, and citation graph.

Diagnosis-based laboratory information system flags to support specialized transfusion protocols in sickle cell disease.

Transfusion·2026

Steatotic Liver Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Case Series and Literature Review.

Hematology reports·2026

The essentials-measurable residual disease in hematopoietic neoplasms: current testing landscape and future directions.

American journal of clinical pathology·2026

Acute leukemias with expression of CD56.

American journal of clinical pathology·2026

Liquid plasma versus thawed plasma: Tracking coagulation factor activity changes during storage.

Vox sanguinis·2026

Leukocytosis and a JAK2 mutation: The importance of expertise in somatic variant interpretation.

Leukemia research reports·2026

ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202.

Bone marrow transplantation·2026

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party.

Bone marrow transplantation·2026

Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article.

Bone marrow transplantation·2026

GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis.

Bone marrow transplantation·2026

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

Bone marrow transplantation·2026

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Bone marrow transplantation·2026

A (Post)translational Opportunity in RAS-Dependent Heme Malignancy.

Blood cancer discovery·2026

Anticoagulation in cancer patients with atrial fibrillation: recent advances.

Polish archives of internal medicine·2026

Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

Blood·2026

Multifocal Glomus Tumors in Different Fingers with Metachronous Clinical Presentation: A Case Report.

Journal of visualized experiments : JoVE·2026

Spatial multi‑omics identifies an SPP1+ macrophage‑driven anti‑apoptotic niche in osteoarthritis synovium via the SPP1‑CD44 axis.

International journal of molecular medicine·2026

The Protective Effect of Selenium versus Ascorbic Acid on Potassium Dichromate-induced Thyroid Toxicity in Adult Male Albino Rats.

Journal of microscopy and ultrastructure·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us